WILLIAM S. STONE, M. D.; GEORGE T. PACK, M.D.; HELEN Q. WOODARD, Ph.D.
At the time of initiation of the lead treatment of cancer by Blair Bell it was claimed1 that lead acted as a specific poison for undifferentiated tissues, whether embryonal or neoplastic. Colloidal lead was used in preference to ionic lead because of its lower toxicity, not because any beneficial action was anticipated from the colloid as such. Later work has shown that lead is deposited more freely in the liver, bones, spleen and kidneys than in the tumor;2 that therapeutic doses do not necessarily induce abortion;3 and that the highly embryonal chorionic epithelioma is not conspicuously lead sensitive.4 The opinion
STONE WS, PACK GT, WOODARD HQ. Experience With the Colloidal Silver Treatment of Cancer*. Ann Intern Med. 1930;3:1149–1156. doi: https://doi.org/10.7326/0003-4819-3-11-1149
Download citation file:
Published: Ann Intern Med. 1930;3(11):1149-1156.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use